Cutaneous malignant tumors: a profile of ten years at LINAR, Larkana-Pakistan
DOI:
https://doi.org/10.66344/jpad.v20i3.405Keywords:
Malignant tumours, cutaneous, basal cell carcinoma, squamous cell carcinomaAbstract
Background Malignant tumors of skin are a group of malignancies comprising primary and metastatic tumors which involve the skin and its appendages.
Patients and methods In this observational study, a total of 300 cases of cutaneous malignant tumors were included, who visited the Larkana Institute of Nuclear Medicine and Radiotherapy (LINAR) for management after confirmation by histopathological examination.
Results Out of 300 cases studied, the males were 195 (65%) and females were 105 (35%), showing M: F ratio of 1.85: 1. The mean age of affected cases was 47±7.694 years and mostly affected patients were farmers (47%). The duration of symptoms in majority of cases (27%) was 3-6 months. Most of the patients (71%) had lesions on face, while other parts of body like extremities, scalp and trunk were involved in 13%, 9% and 7%, respectively. Basal cell carcinoma (BCC) was confirmed in 183 (61%) cases, while squamous cell carcinoma (SCC) and malignant melanoma (MM) were found in 96 (32%) and 21 (7%) cases, respectively.
Conclusion BCC was found to be the commonest morphological type amongst the cutaneous malignant tumors. The increasing incidence rate shows an alarming situation for our population. The unawareness of public and medical professionals about the disease and late diagnosis are contributing factors in high morbidity and mortality.
References
1. Curry MC. Giant basal cell carcinoma. Arch Dermatol 1977; 113: 316-19.
2. Gaughan LG. Giant basal cell epithelioma in acute burn site. Arch Dermatol 1978; 99: 594.
3. Gonclaves J C. A malignant change in smallpox vaccination scar. Arch Dermatol 1966; 93: 229.
4. Ciblin I. Malignant Degeneration in a burn scar. Ann Surg 1965; 162: 291.
5. Oettle AG. Rodent ulcer in identical twins. Arch Dermatol 1956; 74: 167.
6. Burgess GH, Jager BV. Basal cell epithelioma. In: Helm F, ed. Cancer Dermatology. Philadelphia: Lea & Febiger; 1979. P. 91.
7. Baloch Q, Siyal AR, Abbasi S. Pattern of malignant tumors of skin at Larkana. J Coll Physicians Surg Pak 2000; 10: 155-7.
8. Ejaz A. Aurangzeb, Awan ZA. Basal cell carcinoma involving the skin of breast? A rare site. J Pak Assoc Dermatol 2006; 16: 49-51.
9. Mansourai KK, Naveed IA, Kamal F, Chugtai AS. Profile of malignant skin tumors over a period of five years at the department of pathology King Edward Medical College, Lahore. Biomedica 1999; 15: 5-8.
10. Shahryar AH, Chaudhry M, Sarwar G. Clinico-epidemiological analysis of skin cancers. Ann King Edward Med Coll 1998; 4: 82-3
11. Fayyaz GQ, Asim M, Nagra ZM. Basal cell carcinoma; experience at the department of plastic surgery, Allied Hospital, Faisalabad. Professional Med J 2002; 9: 236-40.
12. Memon GA, Memon AR, Kumar M. Basal cell carcinoma in our population: A study of 21 years experience. J Liaquat Uni Med Health Sci 2002; 1: 7-10.
13. Yasmeen N, Saeed S, Kanjee A, Sadiq S. A study of 75 cases of malignant skin tumors. J Pak Assoc Dermatol 2002; 12: 130-4.
14. Ayesha A, Alam MB, Khan W et al. Frequency and characteristics of skin cancers diagnosed at Ayub Medical College Abbottabad. J Ayub Medical Coll Abbottabad 2007; 19: 3-6.
15. Dilnawaz M, Dar NR, Mushtaq S. Malignant melanoma of the skin. A clinico-pathological correlation and therapeutic option. J Pak Assoc Dermatol 2001; 11: 31-3.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Farooq Rahman Soomro, Doulat Rai Bajaj, Ghulam Murtaza Pathan, Parvez Abbasi, Javeed Hussain, Siraj Ahmed Abbasi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
